“Bimekizumab Remission and High Disease Control Over 4 Years in Patients With Psoriasis Achieving Complete Skin Clearance at Week 16: Results from Four Phase 3 Trials”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s758. https://doi.org/10.25251/0bnq3318.